Apotransferrin in Atransferrinemia

Clinical trial NCT01797055 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01797055
Sponsor: Prothya Biosolutions
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Congenital Atransferrinemia

Start date: 2010-12-01
Primary completion: 2022-03-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.